Abstract Cholecystectomy has been identified as a risk factor for colorectal cancer, yet little attention has been given to the relationship between cholecystectomy and colorectal adenomas. Utilizing data collected in two large cross-sectional studies of colorectal adenoma risk factors, we examined the association between cholecystectomy and colorectal adenomas. In the adjusted logistic regression model, both men and women showed no effect of cholecystectomy on risk of colorectal adenomas (men: OR 0.67 [95% CI 0.30-1.47]; women: OR 1.46 [95% CI 0.92-2.29]). No effect was seen when examining the time since cholecystectomy for men. There was a slight association found for women who had a cholecystectomy less than 10 years prior (OR 2.02 [95% CI 1.06-3.87]) but no association was seen in women with cholecystectomy at least 10 years prior (OR 1.14 [95% CI 0.62-2.09]). Thus, we conclude that, although cholecystectomy is a risk factor for colorectal cancer, cholecystectomy is not a risk factor for colorectal adenomas.
Introduction
Cholecystectomy remains one of the most commonly performed operations in the United States. The rates of cholecystectomy have fluctuated in the United States but have remained consistently above 150 per 100,000 people per year since the 1990s [1] . With this number of cholecystectomies being performed, it is important to understand the potential associations between cholecystectomy and disease. The association between cholecystectomy and colorectal adenomas has not been adequately addressed.
Many studies have examined the association between cholecystectomy and colorectal cancer. Two meta-analyses have reported an increased risk of colorectal cancer in those who have undergone a cholecystectomy [2, 3] . Some, but not all, of the studies used in the two meta-analyses overlapped. Both meta-analyses found that the risk of colorectal cancer was higher in the right side of the colon. They also demonstrated a higher risk in women. Since the publication of these meta-analyses, more studies have been published looking at this association. Some found an increase in the risk of proximal colon tumors [4, 5] . One study reported an increase in sigmoid tumors for women who had undergone a cholecystectomy [6] . A study performed only in women found that there was an increase in cancer associated with cholecystectomy, and more specifically, an increase in the risk of proximal colon and rectal cancer [7] . Other studies showed an increased risk of colon cancer after cholecystectomy but no increase for rectal cancer [8] or no association at all between cholecystectomy and advanced colonic neoplasia [9] .
While there have been a number of studies evaluating the association between cholecystectomy and cancer, few have studied the association between cholecystectomy and colorectal adenomas. The meta-analyses performed by Giovannucci et al. analyzed a subset of papers reporting on colorectal adenoma risk as well colorectal cancer risk [3] . Many of these studies lacked an adequate sample size to investigate the association between cholecystectomy and increased risk of colorectal adenomas, and few studies controlled for potential confounders, particularly potentially important confounders such as diet [2, 3] . Failure to allow for a sufficient period of time between cholecystectomy and cancer may also have affected the findings [3] .
Two possible points in tumorigenesis where cholecystectomy could affect colorectal neoplasia have been suggested. First, cholecystectomy might speed the transition of adenomas to cancer. Alternatively, cholecystectomy might increase the risk for adenomas, thereby creating more opportunities for the development of colorectal cancer. Determining which of the above two possible mechanisms is correct will not only provide etiologic information for understanding of the development of colorectal cancer but could potentially have policy and procedural implications. For example, if the increased risk is related to the progression of adenomas into cancer, patients (and their doctors) might take more aggressive measures in terms of screening. In addition, those at higher risk might elect to further modify their lifestyle to lower their risk. In order to further clarify the association between cholecystectomy and colorectal adenomas, we conducted a hospital-based cross-sectional study of cholecystectomy and adenomas that collected information on possible confounders, effect measure modifiers, location of the adenomas in the colon, and time interval between cholecystectomy and adenoma development.
Methods

Study population
The Diet and Health Study III (DHS III) and the Diet and Health Study IV (DHS IV) recruited consecutive patients undergoing an outpatient colonoscopy at the University of North Carolina Hospitals in Chapel Hill, NC from August 1998 to March 2000 (DHS III) and from November 2001 to December 2002 (DHS IV). Eligible patients were between the ages of 30 and 80. Patients were excluded if they did not speak English, or had familial polyposis, colitis, previous colonic resection, or previous colon cancer or adenoma. Eligible patients were asked to consent to a telephone-administered interview and to a rectal biopsy of normal mucosa collected during the colonoscopy.
Data collection
There were 5,621 colonoscopies performed at the University of North Carolina Hospitals during the study period. Of these, 1,677 (30%) were eligible to participate in the study. Exclusions were due to: age (n = 464), familial polyposis (n = 10), colitis (n = 710), previous colonic resection (n = 518), previous colon cancer, adenoma, or polyp (n = 1839), unsatisfactory prep (n = 250), incomplete exam (n = 239), and inability to provide informed consent (n = 338). These reasons are not mutually exclusive. Of the 1,677 eligible patients (926 from DHS III and 751 from DHS IV), 1,437 (86%) consented to be a part of the study and completed the telephone interview. The primary indication for colonoscopy was screening for the vast majority of participants.
A telephone interview was conducted within 12 weeks of the colonoscopy. Patients were asked questions about their lifestyle, including physical activity (asking both amount of time spent doing activities and how strenuous these activities were, which were later converted to metabolic equivalents per day), use of nonsteroidal antiinflammatory drugs (NSAIDs) (asking how many times per day or week a person used NSAIDs), and medical conditions/operations. They were also given a detailed dietary questionnaire. The participants of DHS III were given a modified version of the Block Food Frequency questionnaire [10, 11] . Modification to the questionnaire was made in order to include foods more common in North Carolina, such as hush puppies and black-eyed peas. Subjects in DHS IV were given the NCI Diet History Questionnaire [12] . All subjects were asked to report their diet over the past year (allowing for seasonal fluctuations in patterns of consumption). Participants were questioned about dietary supplements as well.
Since two different dietary questionnaires were used, the values for dietary variables between DHS III and DHS IV could not be directly combined. Instead, the variables were divided into quartiles based on the controls for each study and then combined using their assigned quartile, resulting in categorical dietary variables for each participant. For example, the amount of calories consumed was categorized using quartiles in the control population for DHS III. These quartile cut points were then used to classify the calorie consumption of the cases from DHS III. In a separate step, the calories consumed in DHS IV were categorized using quartiles in the DHS IV control population and applied to the DHS IV cases. The studies were then combined with the calorie consumption based on the quartile of the source study.
Data analysis
Cases were defined as participants who had a colorectal adenoma detected during complete colonoscopy. Location and size of the adenoma were also noted. Participants with no adenomas detected were defined as controls. received a diagnosis of colorectal cancer, they were excluded from the analysis. Information on cholecystectomy was collected during the telephone interview. Participants were asked if they ever had a cholecystectomy, and, if so, how long ago they underwent this procedure.
Missing exposure data was assessed in order to determine if information was missing differentially by outcome. Information about past cholecystectomies was missing for 7.29% of the cases and 7.11% of the controls. While it does not appear that missing exposure data was affected by outcome, those missing this information were excluded from the final analysis.
Logistic regression was used to model the data. Prevalence odds ratios and 95% confidence intervals were calculated using STATA/SE (STATA Corp. 2005. Statistical Software: version 8.2. College Station, TX). In the main analysis, case-control status was used as the outcome variable and prior cholecystectomy was the exposure variable. The following variables were assessed for effect measure modification and for confounding: age (coded as a continuous variable), race (coded as white and non-white), sex (coded as a binary variable), smoking (coded as an indicator variable with three categories: never, former, and current smoker), body mass index (BMI) (coded as a continuous variable), physical activity (coded continuously using current met-minutes per day), NSAID use (coded continuously as number of pills per month), and dietary variables measuring calories, fat, carbohydrates, and fiber consumed (each of these was coded categorically in quartiles using the aforementioned methods). Examination for effect measure modification was performed using the Breslow-Day test of homogeneity. A P-value of 0.15 was used as the cut-off value for classifying a variable as an effect measure modifier. If a variable was determined to be an effect measure modifier, it was entered into the final model along with an interaction term. Prevalence odds ratios and 95% confidence intervals were calculated within each stratum of this variable. Linearity of the logit was also assessed in order to verify the linearity assumption of logistic modeling. All of the variables satisfied this assumption and thus no additional indicator variables were used. Confounding by the variables of interest was assessed using the change-in-estimate approach through backward elimination. The change-in-estimate between the full model and the model without the variable of interest was calculated. If the change was greater than 10% then the variable was considered to be a confounder. In order to avoid deleting observations with missing information on certain covariates, multiple imputation was performed. A regression was run using the missing variable as the dependent variable. The independent variables were those that might allow us to discern the value of this missing variable. Imputation was not performed on any variable with more than 8% of its values missing.
A secondary analysis was undertaken to examine if the risk of colorectal adenomas was greater on a specific side of the colon. Prevalence odds ratios and 95% confidence intervals within the strata of any previously determined effect measure modifier were calculated for the left and right sides of the colon using the controls as the common referent. Adjustments were made for any variables already determined to be confounders. The right side of the colon was defined as the cecum, ascending colon, hepatic flexure, and transverse colon. The left side of the colon was considered the splenic flexure, descending colon, sigmoid colon, and rectum. If a person had an adenoma detected on both the left and right sides of their colon they were excluded from this analysis.
Another analysis was performed to examine the possible change in risk with time since undergoing a cholecystectomy. This was done by categorizing participants based on the amount of time that had passed since their cholecystectomy. Prior studies have used a cut point of 10 years [13, 14] . Therefore, we categorized people as never having a cholecystectomy, having had a cholecystectomy performed less than 10 years before their enrollment in the study, and having undergone a cholecystectomy 10 years or more before becoming part of the study. Then, the prevalence odds ratios and 95% confidence intervals were calculated with adjustment for any previously determined confounders and within the stratum of any effect measure modifiers using the group that had never had a cholecystectomy as the referent population.
Results
A total of 1,334 patients were included in the final study population. Of these, 394 were cases (29.54%) and 940 were controls (70.46%). One hundred fifty-one participants had undergone a cholecystectomy (11.32%). There were more women than men, with women comprising approximately 58% of the study population. The mean age was 56 years. Table 1 gives the characteristics of the study population by case and control status. Cases were older than controls and had slightly higher BMIs. Cases also included more men than women, whereas controls had a higher proportion of women than men. Women in the study population were slightly older than the men, and a higher percentage of women than men had undergone a cholecystectomy.
The only effect measure modifier among the variables of interest was sex. The change-in-estimate approach yielded six confounders. All variables found to be confounders using the change-in-estimate approach were adjusted for in the analyses. The confounders of the prevalence odds ratio were calories (categorical), age (continuous), race (categorical), BMI (continuous), NSAID use (continuous), and daily physical activity (continuous).
When controlling for these covariates, the prevalence odds ratios (POR) and their respective 95% confidence intervals were 0.67 (95% CI: 0.30, 1.47) for men and 1.46 (95% CI: 0.92, 2.29) for women ( Table 2) . While the 95% confidence intervals for men and women included the null values (showing no effect of cholecystectomy on the risk of colorectal adenomas), the prevalence odds ratios were in different directions. The adjusted estimates suggest that cholecystectomy does not increase the risk of developing a colorectal adenoma.
We attempted to determine whether risk increased for adenomas of the left or right side of the colon. Of the 394 cases in the study, one was missing information on location, 141 had adenomas of the left colon, 207 had adenomas of the right colon, and 45 had adenomas on both the left and right colon. There were not enough men to support analysis. Only two men in the study population who had undergone a cholecystectomy had an adenoma detected only on the left side of their colon and only six men had solely right-sided adenomas. Women, on the other hand, had adequate numbers to conduct the analysis but no increase in risk for either side was seen. When compared to controls, the prevalence odds ratio (and 95% confidence interval) for women having an adenoma detected on the left side of the colon was 1.37 (95% CI: 0.70, 2.67). The prevalence odds ratio (and 95% confidence interval) for right-sided adenomas was 1.44 (95% CI: 0.78, 2.66).
In the 10 years prior to entering the study, 70 people had cholecystectomies whereas 76 people had undergone a cholecystectomy at least 10 years before their enrollment in the study. Men showed a decrease in the protective effect of cholecystectomy with increased time since cholecystectomy; however both odds ratios include the null and, therefore, show no effect of cholecystectomy on the risk of colorectal adenomas (Table 3 ). For women, there appears to be a slight increase in risk with cholecystectomy less than 10 years prior (Table 3 ). This risk decreases towards the null when examining women who had a cholecystectomy at least 10 years before entering the study. Of importance, men in our study had a much shorter period of time between cholecystectomy and colonoscopy when compared with the women in our study.
Discussion
After controlling for confounders, this study found that cholecystectomy did not affect the risk of developing colorectal adenomas for men. The risk was reduced by more than 30% in men who underwent a cholecystectomy compared with men who did not, but the 95% confidence intervals were wide and showed no effect of cholecystectomy. Prior studies with sizeable numbers of men have also shown no effect of cholecystectomy in men [13, [15] [16] [17] [18] . We found no effect on the risk of colorectal adenomas for women after having a cholecystectomy. The same was found in subanalysis of both the side of the colon and time since cholecystectomy. The effect seen in women is similar to other studies that found null values after adjusting for confounders [16, 17] . Other studies that have found an increased risk in women had either small sample size or found an increase only in the rectum [7, 13, 15, 18] .
When looking at both sexes, the time since cholecystectomy affects the magnitude of the point estimate. Though the point estimate of the odds ratio for both men and women moves closer to the null, the confidence intervals are too wide to estimate a change in risk with time. Two prior studies found an increased risk of colorectal adenomas with time since cholecystectomy, however these were performed in people 60 years of age and older who had a cholecystectomy performed at least 10 years prior [13, 14] . The study population used in our analysis was not large enough to assess that age group alone. We did however control for age in our analysis.
It has been proposed that removing the gallbladder exposes the intestines to a constant low-level flow of bile, which may modify the environment of the colon [3, 4] . Increasing time does not have an effect on risk. Thus, longer exposure to bile does not increase the risk of colorectal adenomas. Because there appears to be an increased risk of colorectal cancer following cholecystectomy [2, 3] , and because our study has shown that there is no increase in risk for colorectal adenomas, the effects of cholecystectomy on risk of colorectal cancer must occur later in the neoplastic process, after the development of the adenoma. The observed difference in risk when adenomas, as opposed to cancer, are the outcome measure illustrates that different risk factors may occur at different points in the adenoma-carcinoma sequence. Furthermore, this observation illustrates the hazards of using intermediate markers, such as adenomas, as endpoints, as they might falsely reject a risk for cancer.
While this study contributes to the knowledge of cholecystectomy and risk of colorectal adenomas, it has some limitations. First, the sample size is small, limiting further analysis and decreasing precision. Also, the information on cholecystectomy was missing for approximately 7% of the study participants. Dietary practices are assumed to be relatively constant throughout life. If, however, this is not the case, then information on diet 10 or so years prior may have been more informative than the diet recorded and studied in DHS III and DHS IV.
In summary, the present study suggests that cholecystectomy does not affect the risk of colorectal adenomas for men and women. There is no difference in risk seen for the length of time after a cholecystectomy. This study illustrates that the risk factors for intermediate endpoint biomarkers such as adenomas may differ from risk factors for ultimate endpoints such as cancer. Studies of intermediate biomarkers can give potentially misleading results. 
